Noch Fragen? 0800 / 33 82 637

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

Produktform: E-Buch Text Elektronisches Buch in proprietärem

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the study of minimal residual disease and circulating and disseminated tumor cells (CTCs/DTCs) can assist in the understanding of breast cancer metastasis. A series of chapters then discuss the various technologies available for the detection and characterization of CTCs and DTCs, pinpointing their merits and limitations. Detailed consideration is given to the relevance of CTCs and DTCs, and their detection, to clinical research and practice. The role of other blood-based biomarkers is also addressed, and the closing chapters debate the challenges facing drug and biomarker co-development and the use of CTCs for companion diagnostic development. This book will be of interest and assistance to all who are engaged in the modern management of breast cancer.weiterlesen

Dieser Artikel gehört zu den folgenden Serien

Elektronisches Format: PDF

Sprache(n): Englisch

ISBN: 978-3-642-28160-0 / 978-3642281600 / 9783642281600

Verlag: Springer Berlin

Erscheinungsdatum: 23.04.2012

Seiten: 254

Herausgegeben von Michail Ignatiadis, Christos Sotiriou, Klaus Pantel

106,99 € inkl. MwSt.
Recommended Retail Price
kostenloser Versand

sofort lieferbar - Lieferzeit 1-3 Werktage

zurück